{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:21:04Z","timestamp":1781374864999,"version":"3.54.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/pap.0b013e3180ca8a49","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T07:06:32Z","timestamp":1187334392000},"page":"323-334","source":"Crossref","is-referenced-by-count":62,"title":["Diagnostic Uses of Pax5 Immunohistochemistry"],"prefix":"10.1097","volume":"14","author":[{"given":"Andrew L.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","article-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"R2-3-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3880265","article-title":"Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall","volume":"14","author":"Yao","year":"2001","journal-title":"Mod Pathol"},{"key":"R3-3-20210202","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0888-7543(91)90151-4","article-title":"Pax: a murine multigene family of paired box-containing genes","volume":"11","author":"Walther","year":"1991","journal-title":"Genomics"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1101\/gad.4.5.849","article-title":"A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation","volume":"4","author":"Barberis","year":"1990","journal-title":"Genes Dev"},{"key":"R5-3-20210202","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/44076","article-title":"Commitment to the B-lymphoid lineage depends on the transcription factor Pax5","volume":"401","author":"Nutt","year":"1999","journal-title":"Nature"},{"key":"R6-3-20210202","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gad.6.9.1589","article-title":"Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis","volume":"6","author":"Adams","year":"1992","journal-title":"Genes Dev"},{"key":"R7-3-20210202","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.V92.4.1308","article-title":"Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas","volume":"92","author":"Krenacs","year":"1998","journal-title":"Blood"},{"key":"R8-3-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00000478-200210000-00011","article-title":"The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker","volume":"26","author":"Torlakovic","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(01)00153-4","article-title":"Pax5\/BSAP maintains the identity of B cells in late B lymphopoiesis","volume":"14","author":"Horcher","year":"2001","journal-title":"Immunity"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.4049\/jimmunol.158.7.3197","article-title":"Overexpression of B cell-specific activator protein (BSAP\/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype","volume":"158","author":"Usui","year":"1997","journal-title":"J Immunol"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1309\/XEC7-JMW9-YRM7-4RNO","article-title":"Pax-5 expression in nonhematopoietic tissues","volume":"126","author":"Torlakovic","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R12-3-20210202","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1158\/0008-5472.CAN-04-1865","article-title":"PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia","volume":"64","author":"Tiacci","year":"2004","journal-title":"Cancer Res"},{"key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3346\/jkms.2003.18.6.804","article-title":"Pax5 expression in non-Hodgkin's lymphomas and acute leukemias","volume":"18","author":"Zhang","year":"2003","journal-title":"J Korean Med Sci"},{"key":"R15-3-20210202","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1309\/3WG32YRAMQ7RB9D4","article-title":"Lineage determination of CD20-B-Cell neoplasms: an immunohistochemical study","volume":"126","author":"Chu","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y","article-title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma","volume":"186","author":"Pilozzi","year":"1998","journal-title":"J Pathol"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: a heterogeneous tumor. A comprehensive analysis of a series of 27 cases","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/modpathol.3800622","article-title":"Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays","volume":"19","author":"McCune","year":"2006","journal-title":"Mod Pathol"},{"key":"R20-3-20210202","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R21-3-20210202","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"key":"R22-3-20210202","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/modpathol.3800227","article-title":"Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma","volume":"17","author":"Garcia-Cosio","year":"2004","journal-title":"Mod Pathol"},{"key":"R23-3-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1365-2141.2001.03019.x","article-title":"Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis","volume":"114","author":"Foran","year":"2001","journal-title":"Br J Haematol"},{"key":"R24-3-20210202","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/1042819021000040044","article-title":"Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study","volume":"43","author":"Chu","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"R25-3-20210202","first-page":"611","article-title":"Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression","volume":"5","author":"Davis","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R26-3-20210202","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R27-3-20210202","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R28-3-20210202","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"R29-3-20210202","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000478-199812000-00010","article-title":"Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature","volume":"22","author":"Ichinohasama","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R30-3-20210202","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/modpathol.3800169","article-title":"Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray","volume":"17","author":"Lin","year":"2004","journal-title":"Mod Pathol"},{"key":"R31-3-20210202","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1073\/pnas.93.12.6129","article-title":"Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma","volume":"93","author":"Busslinger","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R32-3-20210202","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1182\/blood.V88.11.4110.4110","article-title":"The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene","volume":"88","author":"Iida","year":"1996","journal-title":"Blood"},{"key":"R33-3-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10428199909083377","article-title":"Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32)","volume":"34","author":"Iida","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"R34-3-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gcc.20214","article-title":"PAX5\/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements","volume":"44","author":"Poppe","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"R35-3-20210202","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V92.10.3865","article-title":"Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma","volume":"92","author":"Morrison","year":"1998","journal-title":"Blood"},{"key":"R36-3-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.humpath.2003.10.014","article-title":"Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14)","volume":"35","author":"Cook","year":"2004","journal-title":"Hum Pathol"},{"key":"R37-3-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R38-3-20210202","first-page":"211","article-title":"Hodgkin's disease, lymphocyte predominance type, nodular-further evidence for a B cell derivation: L&H variants of Reed-Sternberg cells express L26, a pan B cell marker","volume":"133","author":"Pinkus","year":"1988","journal-title":"Am J Pathol"},{"key":"R39-3-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1309\/LG0Q0VXYBETJ4VHE","article-title":"Expression of B cell-specific activator protein\/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"126","author":"Valbuena","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R40-3-20210202","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V80.2.470.470","article-title":"Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34","volume":"80","author":"Kita","year":"1992","journal-title":"Blood"},{"key":"R41-3-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.pas.0000155162.33044.4f","article-title":"B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R42-3-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5858\/2005-129-32-MSITB","article-title":"Myeloid sarcoma involving the breast","volume":"129","author":"Valbuena","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R43-3-20210202","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.92.12.5709","article-title":"Deregulated expression of PAX5 in medulloblastoma","volume":"92","author":"Kozmik","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R44-3-20210202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1025652203472","article-title":"The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome","volume":"34","author":"Babjuk","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"R45-3-20210202","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.urology.2005.10.053","article-title":"Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder","volume":"67","author":"Babjuk","year":"2006","journal-title":"Urology"},{"key":"R46-3-20210202","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1464-410x.1999.00052.x","article-title":"The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with de-differentiation","volume":"83","author":"Adshead","year":"1999","journal-title":"BJU Int"},{"key":"R47-3-20210202","first-page":"1003","article-title":"Overexpression of PAX5 in oral carcinogenesis","volume":"16","author":"Norhany","year":"2006","journal-title":"Oncol Rep"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00125480-200709000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T20:37:16Z","timestamp":1684010236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-200709000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e3180ca8a49","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}